Literature DB >> 25832472

NOGGIN: a new therapeutic target for PH? Focus on "Noggin inhibits hypoxia-induced proliferation by targeting store-operated calcium entry and transient receptor potential cation channels".

Olivier Boucherat1, Sébastien Bonnet2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25832472      PMCID： PMC4451347          DOI： 10.1152/ajpcell.00088.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  10 in total

1.  An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.

Authors:  Sébastien Bonnet; Evangelos D Michelakis; Christopher J Porter; Miguel A Andrade-Navarro; Bernard Thébaud; Sandra Bonnet; Alois Haromy; Gwyneth Harry; Rohit Moudgil; M Sean McMurtry; E Kenneth Weir; Stephen L Archer
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

Review 2.  miRNAs in PAH: biomarker, therapeutic target or both?

Authors:  Jolyane Meloche; Aude Pflieger; Mylène Vaillancourt; Colin Graydon; Steeve Provencher; Sébastien Bonnet
Journal:  Drug Discov Today       Date:  2014-06-02       Impact factor: 7.851

3.  Noggin inhibits hypoxia-induced proliferation by targeting store-operated calcium entry and transient receptor potential cation channels.

Authors:  Kai Yang; Wenju Lu; Jing Jia; Jie Zhang; Mingming Zhao; Sabrina Wang; Haiyang Jiang; Lei Xu; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-04       Impact factor: 4.249

4.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.

Authors:  David B Frank; Amir Abtahi; D J Yamaguchi; Suzanne Manning; Yu Shyr; Ambra Pozzi; H Scott Baldwin; Joyce E Johnson; Mark P de Caestecker
Journal:  Circ Res       Date:  2005-08-11       Impact factor: 17.367

6.  Hypoxia regulates BMP4 expression in the murine spleen during the recovery from acute anemia.

Authors:  Dai-Chen Wu; Robert F Paulson
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

7.  Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

Authors:  Ying Yu; Ivana Fantozzi; Carmelle V Remillard; Judd W Landsberg; Naomi Kunichika; Oleksandr Platoshyn; Donna D Tigno; Patricia A Thistlethwaite; Lewis J Rubin; Jason X-J Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

8.  The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.

Authors:  Sebastien Bonnet; Gael Rochefort; Gopinath Sutendra; Stephen L Archer; Alois Haromy; Linda Webster; Kyoko Hashimoto; Sandra N Bonnet; Evangelos D Michelakis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-27       Impact factor: 11.205

Review 9.  STAT3 signaling in pulmonary arterial hypertension.

Authors:  Roxane Paulin; Jolyane Meloche; Sébastien Bonnet
Journal:  JAKSTAT       Date:  2012-10-01

10.  BMP4 increases the expression of TRPC and basal [Ca2+]i via the p38MAPK and ERK1/2 pathways independent of BMPRII in PASMCs.

Authors:  Yi Zhang; Yingfeng Wang; Kai Yang; Lichun Tian; Xin Fu; Yan Wang; Yueqian Sun; Qian Jiang; Wenju Lu; Jian Wang
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240
  10 in total
  3 in total

Review 1.  TRPC channels: Structure, function, regulation and recent advances in small molecular probes.

Authors:  Hongbo Wang; Xiaoding Cheng; Jinbin Tian; Yuling Xiao; Tian Tian; Fuchun Xu; Xuechuan Hong; Michael X Zhu
Journal:  Pharmacol Ther       Date:  2020-01-28       Impact factor: 12.310

2.  Noggin inhibits hypoxia-induced proliferation by targeting store-operated calcium entry and transient receptor potential cation channels.

Authors:  Kai Yang; Wenju Lu; Jing Jia; Jie Zhang; Mingming Zhao; Sabrina Wang; Haiyang Jiang; Lei Xu; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-04       Impact factor: 4.249

3.  Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.

Authors:  Sokratis Kariotis; Emmanuel Jammeh; Emilia M Swietlik; Josephine A Pickworth; Christopher J Rhodes; Pablo Otero; John Wharton; James Iremonger; Mark J Dunning; Divya Pandya; Thomas S Mascarenhas; Niamh Errington; A A Roger Thompson; Casey E Romanoski; Franz Rischard; Joe G N Garcia; Jason X-J Yuan; Tae-Hwi Schwantes An; Ankit A Desai; Gerry Coghlan; Jim Lordan; Paul A Corris; Luke S Howard; Robin Condliffe; David G Kiely; Colin Church; Joanna Pepke-Zaba; Mark Toshner; Stephen Wort; Stefan Gräf; Nicholas W Morrell; Martin R Wilkins; Allan Lawrie; Dennis Wang
Journal:  Nat Commun       Date:  2021-12-07       Impact factor: 17.694
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.